QuidelOrtho (QDEL) Total Non-Current Liabilities (2022 - 2026)
QuidelOrtho (QDEL) reported Total Non-Current Liabilities of $3.7 billion for Q1 2026, up 7.96% on a YoY basis from $3.4 billion in Q1 2025, and little changed sequentially from $3.7 billion in Q4 2025.
QuidelOrtho (QDEL) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
QuidelOrtho (QDEL) has 5 years of Total Non-Current Liabilities data on file, last reported at $3.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 7.96% year-over-year to $3.7 billion; the trailing twelve-month figure through Mar 2026 stood at $3.7 billion (up 7.96% YoY), and the FY2025 full-year result was $3.7 billion, up 8.82% from the prior year.
- Total Non-Current Liabilities held at $3.7 billion in Q1 2026, from $3.7 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $3.8 billion in Q1 2023 to a low of $452.5 million in Q1 2022.
- A 5-year average of $3.4 billion and a median of $3.5 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities surged 748.04% in 2023 and fell 9.55% in 2024, its largest moves.
- Tracing QDEL's Total Non-Current Liabilities over 5 years: stood at $3.8 billion in 2022, then declined by 7.95% to $3.5 billion in 2023, then slipped by 2.59% to $3.4 billion in 2024, then advanced by 8.82% to $3.7 billion in 2025, then dropped by 0.48% to $3.7 billion in 2026.
- Business Quant data shows QDEL's Total Non-Current Liabilities at $3.7 billion in Q1 2026, $3.7 billion in Q4 2025, and $3.5 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | QuidelOrtho | 1.13 Bn | 990.36 Mn | - | 3.66 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 3.66 Bn |
| Dec 28, 2025 | 3.68 Bn |
| Sep 28, 2025 | 3.50 Bn |
| Jun 29, 2025 | 3.45 Bn |
| Mar 30, 2025 | 3.39 Bn |
| Dec 29, 2024 | 3.38 Bn |
| Sep 29, 2024 | 3.50 Bn |
| Jun 30, 2024 | 3.45 Bn |
| Mar 31, 2024 | 3.33 Bn |
| Dec 31, 2023 | 3.47 Bn |
| Oct 1, 2023 | 3.51 Bn |
| Jul 2, 2023 | 3.48 Bn |
| Apr 2, 2023 | 3.68 Bn |
| Jan 1, 2023 | 3.84 Bn |
| Oct 2, 2022 | 3.77 Bn |
| Jul 3, 2022 | 3.82 Bn |
| Jan 2, 2022 | 452.50 Mn |